Skip to content

Clinical application of endoscopic thyroidectomy via a combined transoral and retroauricular approach

Clinical application of endoscopic thyroidectomy via a combined transoral and retroauricular approach

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400089588
Enrollment
Unknown
Registered
2024-09-11
Start date
2024-09-13
Completion date
Unknown
Last updated
2024-09-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

thyroid cancer

Interventions

Endoscopic thyroidectomy via a combined transoral and retroauricular approach group:None

Sponsors

Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University.
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: (1)18-70 years old; (2) Thyroid cancer confirmed by preoperative fine needle aspiration or intraoperative pathology; (3) Tumor diameter less than 4.0 cm; (4) Lateral cervical lymph node metastasis was suggested by neck ultrasound or CT or needle biopsy, or unilateral lateral cervical lymph node dissection was considered necessary after multidisciplinary consultation (MDT). (5) There was no abnormality in laryngoscope before operation; (6) No surgical contraindications; (7) Understand the content of this study and sign the informed consent.

Exclusion criteria

Exclusion criteria: (1) Pregnant or lactating women; (2) History of neck surgery or radiotherapy; (3) The patient was not suitable for surgery; (4) Hyperthyroidism or hypothyroidism; (5) Laparoscopic surgery was converted to open surgery; (6) Severe tumor invasion of adjacent structures such as trachea, esophagus, recurrent laryngeal nerve or tissue adhesion; (7) Distant metastasis; (8) Confluent lymph nodes or single maximum diameter > 3cm; (9) Other patients who were not considered suitable for comparison by the investigator; (10) Patients persisted in withdrawing from the trial.

Design outcomes

Primary

MeasureTime frame
Surgical data;Postoperative data;Postoperative complication;Cosmetic satisfaction;Postoperative quality of life;

Secondary

MeasureTime frame
Demographic data of the patients;VAS score;

Countries

China

Contacts

Public ContactXiaowei Peng

Hunan Cancer Hospital & The Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University

pengxiaowei@hnca.org.cn+86 187 7405 5986

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026